arrow
O

Owen B. McManus

Johns Hopkins University
H指数:47
被引数:7,406
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phenotypic screening platform for chronic pain therapeutics using all-optical electrophysiology
PAIN
IF5.5
2023-11-141
OA
Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells
2022-07-041
OAAI
'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies
2022-05-0110
OAAI
Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls
2022-04-0136
OAAI
The Opioid Crisis and the Future of Addiction and Pain Therapeutics
2019-11-0178
OAAI
Inhale, exhale: Probing the inside-out mechanism of nicotine addiction using novel fluorescent sensors
2019-03-223
OAAI
Scalable Measurements of Intrinsic Excitability in Human iPS Cell-Derived Excitatory Neurons Using All-Optical Electrophysiology
2019-01-0214
PREAI
Assay Guidance Manual: Quantitative Biology and Pharmacology in Preclinical Drug Discovery
2018-07-2437
OAAI
Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels
2017-04-2844
OAAI
Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels
2015-05-1142
OAAI
Identification and Characterization of ML352: A Novel, Noncompetitive Inhibitor of the Presynaptic Choline Transporter
2015-02-0217
OAAI
An old probe sheds new light on BK channel pore structure
2014-11-104
OAAI
Discovery and Characterization of 2-(Cyclopropanesulfonamido)-N-(2-ethoxyphenyl) benzamide, ML382: a Potent and Selective Positive Allosteric Modulator of MrgX1

2-(环丙烷磺酰氨基)-N-(2-乙氧基苯基) 苯甲酰胺的发现和表征,ML382: MrgX1的有效和选择性正变构调节剂

2014-09-109
OAAI
Reversible inhibitors of regulators of G-protein signaling identified in a high-throughput cell-based calcium signaling assay
2013-12-0128
OA
Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile Sulfonamide
2013-09-1317
OA
Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels
2013-05-0670
OA
Aminopiperidine Sulfonamide Cav2.2 Channel Inhibitors for the Treatment of Chronic Pain
2012-11-1227
PREAI
Modulation of hERG potassium channel gating normalizes action potential duration prolonged by dysfunctional KCNQ1 potassium channel
2012-06-2848
OAAI